0
0
Home > Medical Devices >  Diabetes Care Devices >  COVID-19 >  Insulin Pumps and Continuous Glucose Monitors (Diabetes Care Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Insulin Pumps and Continuous Glucose Monitors (Diabetes Care Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Insulin Pumps and Continuous Glucose Monitors (Diabetes Care Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within diabetes care devices therapeutic area.

The model discusses in detail the impact of COVID-19 on the insulin pumps and continuous glucose monitors market for the year 2020 and beyond. People with insulin-dependent diabetes require intensive insulin therapy to manage their blood glucose levels within a healthy range. Insulin can be delivered by syringes and vials, insulin pumps, and insulin pens. Insulin Pumps include Traditional Insulin Pumps & Accessories and Patch Pumps. The continuous glucose monitoring system is used for the continuous measurement of blood glucose. The system includes an implantable sensor with wireless transmission capability and a monitor.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Scope of the Insulin Pumps and Continuous Glucose Monitors (Diabetes Care Devices) market model

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed insulin pumps and continuous glucose monitors and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total insulin pumps and continuous glucose monitors market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices, and market values by segment.
  • Global, Regional, and Country level market-specific insights include qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for insulin pumps and continuous glucose monitors market.
  • Competitive dynamics insights and trends provided for insulin pumps and continuous glucose monitors market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific MedTech regulatory landscape.

What is the Insulin Pumps and Continuous Glucose Monitors market size during the historical and forecast period?

Insulin Pumps And Continuous Glucose Monitors market, by segment

Insulin Pumps And Continuous Glucose Monitors market, by segment

For more segment insights, download a free report sample

What are the key trends within the Insulin Pumps and Continuous Glucose Monitors market?

In North America, the US holds a dominating position in the insulin pumps and CGM market following Canada and Mexico. The market is majorly driven by the increasing prevalence rate of diabetes, increase in the prevalence of obesity, sedentary lifestyle, and increasing awareness among the consumers.

Europe will experience high market growth after North America, due to the increase in the prevalence rate of the diabetic population. In Europe, getting approval for the commercialization of medical devices is typically a faster process than in the US, as a result, medical device manufacturers sometimes will launch new products in the European region before in North America.

Asia-Pacific will witness tremendous growth in the near future as the prevalence number of the diabetic population is increasing at a rapid pace which will lead to higher demand for diabetes care. In some countries, the insulin pump and CGM market are still at a developing stage which can be used as an opportunity to expand the market in emerging economies.

Due to increasing demand, improving healthcare infrastructures, and widening of distribution networks, the South American market grows stably. The prevalence rate of the population suffering from diabetes will continue to increase in the forecast years due to obesity, unhealthy lifestyle, and improperly balanced diet. Innovative and advanced technologies can boost market growth.

Increasing investments in healthcare infrastructure and state-of-the-art medical research facilities in the Middle East & Africa will drive expanded access to insulin pumps and CGMs in the forecast period. The market is expected to grow in the forecast years due to an increase in the prevalence rate of the diabetic population and also the improved reimbursement policies in some countries.

Insulin Pumps and Continuous Glucose Monitors market report scope

Market value (Year – 2021) $19,559.2 million
Segmentation Insulin Pumps and Blood Glucose Meters
Key companies Medtronic plc, DexCom Inc, Abbott Laboratories, Ypsomed Holding AG, Tandem Diabetes Care Inc
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered US, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates

Who are the Insulin Pumps and Continuous Glucose Monitors market vendors?

The model analyses the competitive landscape of the insulin pumps and continuous glucose monitors market and includes information on the following key market vendors:

Medtronic plc, DexCom Inc, Abbott Laboratories, Ypsomed Holding AG, Tandem Diabetes Care Inc.

Reasons to Buy

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have a deep understanding of the insulin pumps and continuous glucose monitors marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

The model will enable you to:

  • Understand the impact of COVID-19 on insulin pumps and continuous glucose monitors
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving insulin pumps and continuous glucose monitors market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the insulin pumps and continuous glucose monitors market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific insulin pumps and continuous glucose monitors market from 2015-2030. Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Companies Mentioned

Medtronic plc

Abbott Laboratories

DexCom Inc

Insulet Corp

F. Hoffmann-La Roche Ltd

Ypsomed Holding AG

Tandem Diabetes Care Inc

Zealand Pharma

Others

Frequently Asked Questions

The insulin pumps and continuous glucose monitors market in 2021 is worth $19,559.2 million.

 

 

The insulin pumps and continuous glucose monitors market has been segmented by product (Insulin Pumps and Blood Glucose Meters), and by 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific).

Key players in the insulin pumps and continuous glucose monitors market are Medtronic plc, DexCom Inc, Abbott Laboratories, Ypsomed Holding AG, and Tandem Diabetes Care Inc.

vThe insulin pumps segment has the largest share of the global insulin pumps and continuous glucose monitors market.

Medtronic plc has the largest market share in the global insulin pumps and continuous glucose monitors market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports